AI can design proteins faster than labs can test them. LenioBio and Twist want to fix that bottleneck
AI can design proteins fast. Biology still sets the pace. LenioBio and Twist Bioscience are targeting drug discovery’s validation gap.
AI can design proteins fast. Biology still sets the pace. LenioBio and Twist Bioscience are targeting drug discovery’s validation gap.
Medra raises $52M to build AI-driven lab robots that run, learn, and optimize experiments. Learn how this startup is redefining drug discovery.